DE69701923T2 - 3-(Piperid-4-yl)-1,2-benzisoxazol- und 3-(Piperazin-4-yl)-1,2-benzisoxazol-Derivate als Antipsychotika - Google Patents

3-(Piperid-4-yl)-1,2-benzisoxazol- und 3-(Piperazin-4-yl)-1,2-benzisoxazol-Derivate als Antipsychotika

Info

Publication number
DE69701923T2
DE69701923T2 DE69701923T DE69701923T DE69701923T2 DE 69701923 T2 DE69701923 T2 DE 69701923T2 DE 69701923 T DE69701923 T DE 69701923T DE 69701923 T DE69701923 T DE 69701923T DE 69701923 T2 DE69701923 T2 DE 69701923T2
Authority
DE
Germany
Prior art keywords
benzisoxazole
piperid
antipsychotics
piperazin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69701923T
Other languages
English (en)
Other versions
DE69701923D1 (de
Inventor
Jean-Louis Peglion
Mark Millan
Mauricette Brocco
Valerie Audinot
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Servier SAS
Original Assignee
ADIR SARL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADIR SARL filed Critical ADIR SARL
Publication of DE69701923D1 publication Critical patent/DE69701923D1/de
Application granted granted Critical
Publication of DE69701923T2 publication Critical patent/DE69701923T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DE69701923T 1996-06-04 1997-06-04 3-(Piperid-4-yl)-1,2-benzisoxazol- und 3-(Piperazin-4-yl)-1,2-benzisoxazol-Derivate als Antipsychotika Expired - Fee Related DE69701923T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9606866A FR2749304B1 (fr) 1996-06-04 1996-06-04 Nouveaux derives du 3-(piperid-4-yl)1,2-benzisoxazole et du 3-(piperazin-4-yl)1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
DE69701923D1 DE69701923D1 (de) 2000-06-15
DE69701923T2 true DE69701923T2 (de) 2000-12-14

Family

ID=9492694

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69701923T Expired - Fee Related DE69701923T2 (de) 1996-06-04 1997-06-04 3-(Piperid-4-yl)-1,2-benzisoxazol- und 3-(Piperazin-4-yl)-1,2-benzisoxazol-Derivate als Antipsychotika

Country Status (19)

Country Link
US (1) US5780474A (de)
EP (1) EP0811622B1 (de)
JP (1) JPH1059967A (de)
CN (1) CN1073565C (de)
AT (1) ATE192745T1 (de)
AU (1) AU715266B2 (de)
BR (1) BR9703447A (de)
CA (1) CA2207835C (de)
DE (1) DE69701923T2 (de)
DK (1) DK0811622T3 (de)
ES (1) ES2148916T3 (de)
FR (1) FR2749304B1 (de)
GR (1) GR3033996T3 (de)
HU (1) HUP9700992A3 (de)
NO (1) NO308360B1 (de)
NZ (1) NZ314992A (de)
PL (1) PL187005B1 (de)
PT (1) PT811622E (de)
ZA (1) ZA974919B (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7168084B1 (en) 1992-12-09 2007-01-23 Sedna Patent Services, Llc Method and apparatus for targeting virtual objects
US9286294B2 (en) 1992-12-09 2016-03-15 Comcast Ip Holdings I, Llc Video and digital multimedia aggregator content suggestion engine
US6263443B1 (en) * 1997-10-11 2001-07-17 Agere Systems Guardian Corp. Simplified data link protocol processor
CA2320120C (en) * 1998-02-09 2009-08-11 Duphar International Research Bv Benzisoxazole derivatives having d4-antagonistic activity
US6754905B2 (en) 1998-07-23 2004-06-22 Diva Systems Corporation Data structure and methods for providing an interactive program guide
US9924234B2 (en) 1998-07-23 2018-03-20 Comcast Ip Holdings I, Llc Data structure and methods for providing an interactive program
WO2000005891A1 (en) * 1998-07-23 2000-02-03 Diva Systems Corporation Interactive user interface
US6107313A (en) * 1998-10-02 2000-08-22 Combichem, Inc. Dopamine receptor antagonists
US6754271B1 (en) 1999-04-15 2004-06-22 Diva Systems Corporation Temporal slice persistence method and apparatus for delivery of interactive program guide
US6904610B1 (en) 1999-04-15 2005-06-07 Sedna Patent Services, Llc Server-centric customized interactive program guide in an interactive television environment
US7096487B1 (en) 1999-10-27 2006-08-22 Sedna Patent Services, Llc Apparatus and method for combining realtime and non-realtime encoded content
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
US7125903B1 (en) 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
MXPA02002694A (es) * 1999-09-14 2002-07-30 Aventis Pharm Prod Inc Derivados de benzisoxazolil-, piridoisoxazolil-y benzotienil-fenoxi utiles como antagonistas de d4.
WO2001031914A1 (en) 1999-10-27 2001-05-03 Diva Systems Corporation Picture-in-picture and multiple video streams using slice-based encoding
FR2803298A1 (fr) * 1999-12-30 2001-07-06 Adir Nouvelles urees lineaires ou cycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2001292276A1 (en) * 2000-09-27 2002-04-08 Toray Industries, Inc. Nitrogen-containing compounds and ccr3 inhibitors containing the same as the active ingredient
US7908628B2 (en) 2001-08-03 2011-03-15 Comcast Ip Holdings I, Llc Video and digital multimedia aggregator content coding and formatting
US7793326B2 (en) 2001-08-03 2010-09-07 Comcast Ip Holdings I, Llc Video and digital multimedia aggregator
US20050119249A1 (en) * 2003-12-02 2005-06-02 Erik Buntinx Method of treating neurodegenerative diseases using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7855195B2 (en) * 2003-12-02 2010-12-21 Pharmaneuroboost N.V. Method of treating mental disorders using D4 and 5-HT2A antagonists, inverse agonists or partial agonists
US7884096B2 (en) * 2003-12-02 2011-02-08 Pharmaneuroboost N.V. Method of treating mental disorders using of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
WO2005053796A1 (en) * 2003-12-02 2005-06-16 B & B Beheer Nv Use of d4 and 5-ht2a antagonists, inverse agonists or partial agonists
EP1547650A1 (de) * 2003-12-02 2005-06-29 B & B Beheer NV Verwendung von D4 und 5-HT2A Antagonisten, inverse Agonisten order partielle Agonisten
US20050203130A1 (en) * 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
JP4970290B2 (ja) * 2005-02-25 2012-07-04 ファイザー株式会社 ベンズイソキサゾール誘導体
BRPI0919342A2 (pt) * 2008-09-23 2015-12-29 Hoffmann La Roche derivados do isoxazol [4,5] piridin-3-il-piperazina, seu processo de preparação, seu medicamento e seu uso
AU2009296045B2 (en) * 2008-09-23 2013-07-04 F. Hoffmann-La Roche Ag Benzo[d]isoxazol-3-yl-piperazin derivatives useful as modulators of dopamine D3 receptors
US9154813B2 (en) 2011-06-09 2015-10-06 Comcast Cable Communications, Llc Multiple video content in a composite video stream

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754641A (fr) * 1969-08-11 1971-02-10 Geigy Ag J R Derives de l'imidazolidinone et medicaments contenant de tels derives
US4352811A (en) * 1981-11-12 1982-10-05 Hoechst-Roussel Pharmaceuticals Inc. 3-(1-Substituted-4-piperidyl)-1,2-benzisoxazoles
US4458076A (en) * 1983-05-31 1984-07-03 Hoechst-Roussel Pharmaceuticals 3-(4-Piperidinyl)-1,2-benzisothiazoles
CA1335289C (en) * 1987-10-26 1995-04-18 Fujio Antoku Piperidinyl benzisoxazole derivatives, their production and pharmaceutical use
US5776963A (en) * 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
KR0179063B1 (ko) * 1993-02-04 1999-03-20 사사이 아키라 항정신병 작용을 갖는 화합물

Also Published As

Publication number Publication date
NO308360B1 (no) 2000-09-04
CN1171401A (zh) 1998-01-28
DK0811622T3 (da) 2000-09-11
US5780474A (en) 1998-07-14
EP0811622A1 (de) 1997-12-10
CA2207835C (fr) 2001-10-02
NO972510L (no) 1997-12-05
PL320325A1 (en) 1997-12-08
ZA974919B (en) 1997-12-30
FR2749304A1 (fr) 1997-12-05
HUP9700992A3 (en) 1999-03-29
NO972510D0 (no) 1997-06-02
GR3033996T3 (en) 2000-11-30
ES2148916T3 (es) 2000-10-16
PT811622E (pt) 2000-08-31
DE69701923D1 (de) 2000-06-15
ATE192745T1 (de) 2000-05-15
JPH1059967A (ja) 1998-03-03
NZ314992A (en) 1999-05-28
BR9703447A (pt) 1998-11-10
EP0811622B1 (de) 2000-05-10
PL187005B1 (pl) 2004-04-30
CN1073565C (zh) 2001-10-24
CA2207835A1 (fr) 1997-12-04
AU715266B2 (en) 2000-01-20
HU9700992D0 (en) 1997-07-28
HUP9700992A2 (hu) 1998-12-28
FR2749304B1 (fr) 1998-06-26
AU2464997A (en) 1997-12-11

Similar Documents

Publication Publication Date Title
ATE192745T1 (de) 3-(piperid-4-yl)-1,2-benzisoxazol- und 3- (piperazin-4-yl)-1,2-benzisoxazol-derivate als antipsychotika
IL115572A0 (en) Novel substituted 4-(azanaphthoylamino)-piperidines salts of these and pharmaceutical compositions containing them
NO933976L (no) Nye perhydroisoindolderivater og deres fremstilling
NO962210D0 (no) Nye piperazin, piperidin og tetrahydropyridinforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetninger inneholdende dem
DE69206274T2 (de) 3-ureido-benzodiazepinone verwendbar als cck- oder gastrin-antagonisten.
AU6798190A (en) Serotonin antagonists, their preparation and compositions containing them
DK0947504T3 (da) 16-en-vitamin D-derivater
NO984597L (no) Amino- og hydroksysubstituerte trifenyl-s-triaziner som stabilisatorer
UY27578A1 (es) Benzotiazoles
SE8605458L (sv) 4-hydroxikumaring-derivat
DK0592571T3 (da) Derivater af 1,2,4-thiadiazino(3,4-b)benzothiazol, deres fremstilling og lægemidler indeholdende disse forbindelser
DK1023287T3 (da) Derivater af 3-oxo-(2H)-1,2,4-triazin som ligander for 5HT1a-receptorer
ATE148462T1 (de) Isoxazole derivate als lichtschutzmittel
FR2823749A1 (fr) Phenyl- et pyridyl-piperidines, procede pour leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LES LABORATOIRES SERVIER, NEUILLY SUR SEINE, FR

8339 Ceased/non-payment of the annual fee